Begoña Quintana-Villamandos

8PUBLICATIONS
8CO-AUTHORS
Toxicology (incl. clinical toxicology)Predictive and prognostic markersMedical devicesMolecular medicineCell physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 09, 2025
Vitamin D as an add-on therapy to phosphodiesterase-5 inhibitor in experimental pulmonary arterial hypertension.

Rui Adão, Bianca Barreira, Elena Paternoster

|Jul 11, 2020
OXY-SCORE: a new perspective for left ventricular hypertrophy diagnosis.

Begoña Quintana-Villamandos, Laia Pazó-Sayós, Irene González Del Pozo

|Jul 30, 2019
Impact of a Multichannel Blocker in Attenuating Intramyocardial Artery Remodeling in Hypertensive Rats through Increased Nitric Oxide Bioavailability.

Begoña Quintana-Villamandos, María Jesús Delgado-Martos, Emilio Delgado-Baeza

|May 09, 2019
Plasma protein thiolation index (PTI) as a potential biomarker for left ventricular hypertrophy in humans.

Begoña Quintana-Villamandos, Irene González Del Pozo, Laia Pazó-Sayós

|Apr 20, 2018
Short-Term Treatment with Esmolol Reverses Left Ventricular Hypertrophy in Adult Spontaneously Hypertensive Rats via Inhibition of Akt/NF-κB and NFATc4.

Begoña Quintana-Villamandos, David A Goukassian, Sharath P Sasi

Pageof 2